{"count": 18, "results": [{"_id": "32098266", "pmid": 32098266, "pmcid": "PMC7073047", "title": "Metformin Alleviates Left Ventricular Diastolic Dysfunction in a Rat Myocardial Ischemia Reperfusion Injury Model", "journal": "Int J Mol Sci", "authors": ["Jo W", "Kang KK", "Chae S", "Son WC"], "date": "2020-02-21T00:00:00Z", "doi": "10.3390/ijms21041489", "meta_date_publication": "2020 Feb 21", "meta_volume": "21", "meta_issue": "4", "meta_pages": "", "score": 50256.277, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Alleviates @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@Left Ventricular Diastolic Dysfunction@@@ in a @SPECIES_10116 @@@Rat@@@ @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@Myocardial Ischemia@@@ Reperfusion @DISEASE_Wounds_and_Injuries @DISEASE_MESH:D014947 @@@Injury@@@ Model", "citations": {"NLM": "Jo W, Kang KK, Chae S, Son WC. Metformin Alleviates Left Ventricular Diastolic Dysfunction in a Rat Myocardial Ischemia Reperfusion Injury Model Int J Mol Sci. 2020 Feb 21;21(4):. PMID: 32098266", "BibTeX": "@article{32098266, title={Metformin Alleviates Left Ventricular Diastolic Dysfunction in a Rat Myocardial Ischemia Reperfusion Injury Model}, author={Jo W and Kang KK and Chae S and Son WC}, journal={Int J Mol Sci}, volume={21}, number={4}}"}}, {"_id": "33830437", "pmid": 33830437, "title": "Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial.", "journal": "Endocrine", "authors": ["Ladeiras-Lopes R", "Sampaio F", "Leite S", "Santos-Ferreira D", "Vilela E", "Leite-Moreira A", "Bettencourt N", "Gama V", "Braga P", "Fontes-Carvalho R"], "date": "2021-06-01T00:00:00Z", "doi": "10.1007/s12020-021-02687-0", "meta_date_publication": "2021 Jun", "meta_volume": "72", "meta_issue": "3", "meta_pages": "699-710", "score": 50255.574, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ and @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@diastolic dysfunction@@@: the MET-DIME randomized trial.", "citations": {"NLM": "Ladeiras-Lopes R, Sampaio F, Leite S, Santos-Ferreira D, Vilela E, Leite-Moreira A, Bettencourt N, Gama V, Braga P, Fontes-Carvalho R. Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial. Endocrine. 2021 Jun;72(3):699-710. PMID: 33830437", "BibTeX": "@article{33830437, title={Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial.}, author={Ladeiras-Lopes R and Sampaio F and Leite S and Santos-Ferreira D and Vilela E and Leite-Moreira A and Bettencourt N and Gama V and Braga P and Fontes-Carvalho R}, journal={Endocrine}, volume={72}, number={3}, pages={699-710}}"}}, {"_id": "33439743", "pmid": 33439743, "title": "Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury.", "journal": "Arch Physiol Biochem", "authors": ["Al-Ani B", "Alzamil NM", "Hewett PW", "Al-Hashem F", "Bin-Jaliah I", "Shatoor AS", "Kamar SS", "Latif NSA", "Haidara MA", "Dawood AF"], "date": "2021-01-13T00:00:00Z", "doi": "10.1080/13813455.2020.1869265", "meta_date_publication": "2021 Jan 13", "meta_volume": "", "meta_issue": "", "meta_pages": "1-7", "score": 50252.57, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates ROS-@GENE_P53_PS @GENE_301300 @@@p53@@@-collagen axis of @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ and @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@-induced @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@left ventricular injury@@@.", "citations": {"NLM": "Al-Ani B, Alzamil NM, Hewett PW, Al-Hashem F, Bin-Jaliah I, Shatoor AS, Kamar SS, Latif NSA, Haidara MA, Dawood AF. Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury. Arch Physiol Biochem. 2021 Jan 13;():1-7. PMID: 33439743", "BibTeX": "@article{33439743, title={Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury.}, author={Al-Ani B and Alzamil NM and Hewett PW and Al-Hashem F and Bin-Jaliah I and Shatoor AS and Kamar SS and Latif NSA and Haidara MA and Dawood AF}, journal={Arch Physiol Biochem}, pages={1-7}}"}}, {"_id": "37631036", "pmid": 37631036, "pmcid": "PMC10459572", "title": "Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms", "journal": "Pharmaceuticals (Basel)", "authors": ["Osorio-Llanes E", "Villamizar-Villamizar W", "Ospino Guerra MC", "Díaz-Ariza LA", "Castiblanco-Arroyave SC", "Medrano L", "Mengual D", "Belón R", "Castellar-López J", "Sepúlveda Y", "Vásquez-Trincado C", "Chang AY", "Bolívar S", "Mendoza-Torres E"], "date": "2023-08-09T00:00:00Z", "doi": "10.3390/ph16081121", "meta_date_publication": "2023 Aug 9", "meta_volume": "16", "meta_issue": "8", "meta_pages": "", "score": 50251.535, "text_hl": "...2. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@", "citations": {"NLM": "Osorio-Llanes E, Villamizar-Villamizar W, Ospino Guerra MC, Díaz-Ariza LA, Castiblanco-Arroyave SC, Medrano L, Mengual D, Belón R, Castellar-López J, Sepúlveda Y, Vásquez-Trincado C, Chang AY, Bolívar S, Mendoza-Torres E. Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms Pharmaceuticals (Basel). 2023 Aug 9;16(8):. PMID: 37631036", "BibTeX": "@article{37631036, title={Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms}, author={Osorio-Llanes E and Villamizar-Villamizar W and Ospino Guerra MC and Díaz-Ariza LA and Castiblanco-Arroyave SC and Medrano L and Mengual D and Belón R and Castellar-López J and Sepúlveda Y and Vásquez-Trincado C and Chang AY and Bolívar S and Mendoza-Torres E}, journal={Pharmaceuticals (Basel)}, volume={16}, number={8}}"}}, {"_id": "31711850", "pmid": 31711850, "title": "Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.", "journal": "Int J Cardiol", "authors": ["Gu J", "Yin ZF", "Zhang JF", "Wang CQ"], "date": "2020-05-01T00:00:00Z", "doi": "10.1016/j.ijcard.2019.11.087", "meta_date_publication": "2020 May 1", "meta_volume": "306", "meta_issue": "", "meta_pages": "140-145", "score": 50244.57, "text_hl": "CONCLUSIONS: Long-term @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exposure was associated with protective effects in terms of the incidence of new-onset symptomatic HFpEF, @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@LV diastolic dysfunction and hypertrophy@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, which might be beneficial for the delay of HFpEF progression.", "citations": {"NLM": "Gu J, Yin ZF, Zhang JF, Wang CQ. Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension. Int J Cardiol. 2020 May 1;306():140-145. PMID: 31711850", "BibTeX": "@article{31711850, title={Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension.}, author={Gu J and Yin ZF and Zhang JF and Wang CQ}, journal={Int J Cardiol}, volume={306}, pages={140-145}}"}}, {"_id": "37389952", "pmid": 37389952, "title": "Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.", "journal": "Am J Physiol Heart Circ Physiol", "authors": ["McNair BD", "Polson SM", "Shorthill SK", "Yusifov A", "Walker LA", "Weiser-Evans MCM", "Kovacs EJ", "Bruns DR"], "date": "2023-06-30T00:00:00Z", "doi": "10.1152/ajpheart.00124.2023", "meta_date_publication": "2023 Jun 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50242.6, "text_hl": "The anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug and AMP-activated protein kinase (AMPK) activator @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@left ventricular dysfunction@@@, suggesting cardioprotective properties may translate to the RV. ", "citations": {"NLM": "McNair BD, Polson SM, Shorthill SK, Yusifov A, Walker LA, Weiser-Evans MCM, Kovacs EJ, Bruns DR. Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK. Am J Physiol Heart Circ Physiol. 2023 Jun 30;():. PMID: 37389952", "BibTeX": "@article{37389952, title={Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK.}, author={McNair BD and Polson SM and Shorthill SK and Yusifov A and Walker LA and Weiser-Evans MCM and Kovacs EJ and Bruns DR}, journal={Am J Physiol Heart Circ Physiol}}"}}, {"_id": "24515256", "pmid": 24515256, "title": "METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial.", "journal": "Cardiovasc Drugs Ther", "authors": ["Ladeiras-Lopes R", "Fontes-Carvalho R", "Bettencourt N", "Sampaio F", "Gama V", "Leite-Moreira AF"], "date": "2014-04-01T00:00:00Z", "doi": "10.1007/s10557-014-6512-2", "meta_date_publication": "2014 Apr", "meta_volume": "28", "meta_issue": "2", "meta_pages": "191-6", "score": 50074.984, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@METformin@@@ in @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@DIastolic Dysfunction of MEtabolic syndrome@@@ (@<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@MET-DIME@@@) trial: rationale and study design : @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@MET-DIME@@@ trial.", "citations": {"NLM": "Ladeiras-Lopes R, Fontes-Carvalho R, Bettencourt N, Sampaio F, Gama V, Leite-Moreira AF. METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial. Cardiovasc Drugs Ther. 2014 Apr;28(2):191-6. PMID: 24515256", "BibTeX": "@article{24515256, title={METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial.}, author={Ladeiras-Lopes R and Fontes-Carvalho R and Bettencourt N and Sampaio F and Gama V and Leite-Moreira AF}, journal={Cardiovasc Drugs Ther}, volume={28}, number={2}, pages={191-6}}"}}, {"_id": "10684514", "pmid": 10684514, "title": "Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium.", "journal": "J Cardiovasc Pharmacol Ther", "authors": ["Jyothirmayi GN", "Soni BJ", "Masurekar M", "Lyons M", "Regan TJ"], "date": "1998-10-01T00:00:00Z", "doi": "10.1177/107424849800300407", "meta_date_publication": "1998 Oct", "meta_volume": "3", "meta_issue": "4", "meta_pages": "319-326", "score": 50067.535, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Collagen Glycation and @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@Diastolic Dysfunction@@@ in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic Myocardium@@@.", "citations": {"NLM": "Jyothirmayi GN, Soni BJ, Masurekar M, Lyons M, Regan TJ. Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium. J Cardiovasc Pharmacol Ther. 1998 Oct;3(4):319-326. PMID: 10684514", "BibTeX": "@article{10684514, title={Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium.}, author={Jyothirmayi GN and Soni BJ and Masurekar M and Lyons M and Regan TJ}, journal={J Cardiovasc Pharmacol Ther}, volume={3}, number={4}, pages={319-326}}"}}, {"_id": "26068409", "pmid": 26068409, "title": "The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.", "journal": "Cardiovasc Drugs Ther", "authors": ["Abualsuod A", "Rutland JJ", "Watts TE", "Pandat S", "Delongchamp R", "Mehta JL"], "date": "2015-06-01T00:00:00Z", "doi": "10.1007/s10557-015-6601-x", "meta_date_publication": "2015 Jun", "meta_volume": "29", "meta_issue": "3", "meta_pages": "265-75", "score": 50059.93, "text_hl": "The Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use on @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@Left Ventricular@@@ Ejection Fraction and @DISEASE_Death @DISEASE_MESH:D003643 @@@Mortality@@@ Post-@DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@Myocardial Infarction@@@.", "citations": {"NLM": "Abualsuod A, Rutland JJ, Watts TE, Pandat S, Delongchamp R, Mehta JL. The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovasc Drugs Ther. 2015 Jun;29(3):265-75. PMID: 26068409", "BibTeX": "@article{26068409, title={The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction.}, author={Abualsuod A and Rutland JJ and Watts TE and Pandat S and Delongchamp R and Mehta JL}, journal={Cardiovasc Drugs Ther}, volume={29}, number={3}, pages={265-75}}"}}, {"_id": "27977774", "pmid": 27977774, "pmcid": "PMC5158040", "title": "The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction", "journal": "PLoS One", "authors": ["Al Ali L", "Hartman MT", "Lexis CP", "Hummel YM", "Lipsic E", "van Melle JP", "van Veldhuisen DJ", "Voors AA", "van der Horst IC", "van der Harst P"], "date": "2016-12-15T00:00:00Z", "doi": "10.1371/journal.pone.0168340", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "12", "meta_pages": "e0168340", "score": 50055.668, "text_hl": "After 4 months 22 (19%) of @SPECIES_9606 @@@patients@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and 18 (15%) @SPECIES_9606 @@@patients@@@ with placebo (P = 0.47) had @<m>DISEASE_Ventricular_Dysfunction_Left</m> @DISEASE_MESH:D018487 @@@diastolic dysfunction@@@. ", "citations": {"NLM": "Al Ali L, Hartman MT, Lexis CP, Hummel YM, Lipsic E, van Melle JP, van Veldhuisen DJ, Voors AA, van der Horst IC, van der Harst P. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction PLoS One. 2016;11(12):e0168340. PMID: 27977774", "BibTeX": "@article{27977774, title={The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction}, author={Al Ali L and Hartman MT and Lexis CP and Hummel YM and Lipsic E and van Melle JP and van Veldhuisen DJ and Voors AA and van der Horst IC and van der Harst P}, journal={PLoS One}, volume={11}, number={12}, pages={e0168340}}"}}]}